Drug Type Small molecule drug |
Synonyms MBF 362, MBF-362 |
Target |
Mechanism EP4 antagonists(Prostanoid EP4 receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Phase 1 | ES | 24 Nov 2022 |